Wadsworth Center

Despite the astronomical costs, it may prove challenging to reverse course and discontinue Zika testing according to a commentary article accompanying a NEJM study.

The assay was developed in the Wadsworth Center Biodefense Laboratory and includes a novel sample prep enabling detection from stool.

The University at Albany this week announced that scientists from its RNA Institute have begun collaborating with researchers from the Wadsworth Center of the New York State Department of Health and Rensselaer Polytechnic Institute to advance new biomedical technologies.

Akonni Biosystems and Albany, NY-based Wadsworth Center are working together under a $300,000 National Institutes of Health grant to develop a closed amplicon PCR microarray to detect encephalitis- and meningitis-causing viruses in cerebral spinal fluid, Akonni said this week.

Agilent Technologies, Columbia University, and others are collaborating on development of the system, which will be based on MassTag PCR.

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.